Facet Biotech

Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of 450 million in cash, in a move aimed at expanding its drug pipeline, including for treatments for multiple sclerosis. Abbott to Buy Facet Biotech for 67 Premium – DealBook Blog. FACET BANNER HOME J. imagetitle. The strength of our balance sheet and our strategic collaborations with major biotechnology and pharmaceutical companies . Facet Biotech – Homepage Our perspective itaposs what sets us apart Facet Biotech – Homepage

Facet Biotech


Facet Biotech – Overview With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech offers excellent opportunities for career . Abbott paying 450 million for Facet Biotech NEW YORK Abbott Laboratories says it will buy Facet Biotech for about 450 million in cash, expanding the company’s access to biotechnology drugs, including a potential treatment for . Overview Benefits Our Values Job Postings : With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech offers excellent opportunities . Abbott paying 450 million for Facet Biotech, expands access to. Facet Biotech – Overview

Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott’s Existing Diverse Oncology Program. Shares of drug maker Facet Biotech skyrocket after Abbott announced an acquisition bid valuing Facet at 27 a share. check out thestreet for the latest stock market news and . Facet Biotech Stock Soars on Abbott Bid Biotech Financial Articles . Abbott Agrees to Buy Facet Biotech for 450 Million Update2. Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet. Abbott Laboratories, maker of the arthritis drug Humira, agreed to buy Facet Biotech Corp. for 27 a share in cash, for a net 450 million, .

Commentary: Facet Biotech Stock Soars on Abbott Bid Biotech . Facet Biotech – News Investors – Investor Relations Home With several products currently in the clinic and a long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company . World Pharma News – Abbott Enhances Pharmaceutical Pipeline with. Abbott NYSE: ABT and Facet Biotech Corporation Nasdaq: FACT announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott’s early- and mid-stage pharmaceutical pipeline. Abbott will acquire Facet for 27 per . Commentary: Shares of drug maker Facet Biotech skyrocket after Abbott announced an acquisition bid valuing Facet at 27 a share. Check out TheStreet for the latest stock market .

ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 ots/PRNewswire — Abbott and Facet Biotech Corporation announced today a definitive. Abbott Agrees to Buy Facet Biotech for 450 Million Update2 . Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet. Get detailed information on Facet Biotech Corporation FACT including quote performance, Real-Time ECN, technical chart analysis, key stats, . FACT: Summary for Facet Biotech Corporation- Yahoo Finance bn:WBTKRABT:US Abbott Laboratories , maker of the arthritis drug Humira, agreed to buy bn:WBTKRFACT:US Facet Biotech Corp. for 27 a share in cash, for a net 450 .

PRESSEMITTEILUNGEN – Abbott Enhances Pharmaceutical Pipeline with. Abbott to Buy Facet Biotech for 67 Premium – DealBook Blog. NEW YORK — Abbott Laboratories says it will buy Facet Biotech for about 450 million in cash, expanding the companyaposs access to biotechnology drugs, including a potential . Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech. Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of 450 million in cash, in a move aimed . Abbott paying 450 million for Facet Biotech

Facet Biotech Corporation – Google Finance Facet Biotech Corp. will be’ bought for 450 million in cash by Abbott Laboratories. Abbott to pay 450 million for Facet Biotech Abbott, based in North . Facet Biotech Corp Abbott Buyout Deal Daily Postal NEW YORK – Abbott Laboratories says it will buy Facet Biotech for about 450 million in cash, expanding the companyaposs access to biotechnology drugs, including a potential . Get the latest on Facet Biotech Corporation including up to date news, high quality discussion groups and more on Google Finance. Abbott paying 450 million for Facet Biotech, expands access to .

Sells Wall Street related stock market, bond market designs on T-shirts, mugs and other unique custom gift items. Perfect for hedge fund managers, traders, investment bankers, analysts, investors, MBAs and anyone interested in the . Business Technology Abbott paying 450 million for Facet Biotech . Abbott to Buy Facet Biotech Wall Street Journal Wall Street. Abbott paying 450 million for Facet Biotech Abbott Laboratories says it will buy Facet Biotech for about 450 million in cash, expanding the companyaposs access to biotechnology . I originally disagreed with this Seeking Alpha article which claimed Facet Biotech Inc FACT was a current Seth Klarman favorite. . What Does Seth Klarman See in Facet Biotech — Seeking Alpha